Search for: "Ranbaxy Laboratories Ltd."
Results 1 - 20
of 70
Sorted by Relevance
|
Sort by Date
16 Sep 2008, 4:36 pm
Food and Drug Administration has issued two Warning Letters to Ranbaxy Laboratories, Ltd., an India-based manufacturer of generic drugs, some for the U.S. market. [read post]
26 Jul 2007, 9:52 pm
By Donald Zuhn -- Ranbaxy Laboratories Ltd. announced today (July 26, 2007) that it had reached an agreement with GlaxoSmithKline in which GlaxoSmithKline would dismiss its patent infringement suit against Ranbaxy. [read post]
24 Jan 2014, 7:36 am
Ranbaxy Laboratories Ltd. can’t make or distribute drug ingredients from a fourth plant in India for the U.S. market, regulators ordered. [read post]
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the… [read post]
17 Sep 2008, 8:24 pm
See the Notice here: FDA Issues Warning Letters to Ranbaxy Laboratories Ltd., and an Import Alert for Drugs from Two Ranbaxy Plants in India [read post]
8 Aug 2010, 8:32 pm
• Defendants: Ranbaxy Laboratories Ltd.; Ranbaxy Pharmaceuticals Inc.; Ranbaxy, Inc.; Ethypharm S.A. [read post]
29 Dec 2011, 12:35 am
According to the company’s announcement: Ranbaxy Laboratories Ltd. [read post]
28 Dec 2011, 2:09 pm
Image via Wikipedia Last week, India’s largest drug manufacturer, Ranbaxy Laboratories Ltd., announced that it had entered into a consent decree with the Food and Drug Administration (FDA) and had set aside a provision of $500 million to cover any liability arising out of a separate investigation by the Department of Justice (DOJ). [read post]
26 Feb 2009, 8:23 am
Food and Drug Administration has prohibited Ranbaxy Laboratories Ltd., India's largest drug manufacturer, from introducing new generic drugs from one of its factories after it falsified data about products' shelf life. [read post]
14 Mar 2014, 8:01 am
Indian drug maker Ranbaxy Laboratories Ltd. is facing harsh criticism after issuing a recall for more than 60,000 bottles of its generic cholesterol-lowering drug Lipitor. [read post]
30 Sep 2013, 8:12 am
(NYSE:FRX) and Forest Laboratories Holdings, Ltd. [read post]
18 Jun 2008, 12:41 pm
The Lipitor Scorecard has been updated, so go and have a look at the latest results - across 23 countries.For those keen on a little pharmaceutical patent blood sport, don't despair, the battle wages on in five European counries: Finland, Spain, Portugal, Denmark and RomaniaHere's the press release from Pfizer: Pfizer and Ranbaxy Settle Lipitor Patent Litigation (mostly) Worldwide Ranbaxy to Receive License in U.S. on November 30, 2011; NEW YORK--(BUSINESS WIRE)--Pfizer… [read post]
13 May 2013, 7:58 am
Ranbaxy Laboratories, Ltd., et al. , Case No. [read post]
8 Jul 2012, 1:58 pm
Five big U.S. retailers filed an antitrust lawsuit against Pfizer Inc and India's Ranbaxy Laboratories Ltd on Thursday, accusing them of conspiring to delay sales of generic versions of Lipitor, the best-selling drug in history. [read post]
17 Oct 2007, 10:00 pm
Reddy's Laboratories; Watson; Zambon andApotex. [read post]
3 Jul 2014, 7:42 am
The article pointed out that Sun this month unveiled a plan to buy Ranbaxy Laboratories Ltd., which itself has come under FDA scrutiny, with four of its plants banned by the FDA. [read post]
4 Aug 2006, 8:56 am
Earlier, a Delaware District Court ruled that Pfizer can exclusively sell Lipitor until 2011 after finding that Ranbaxy Laboratories Ltd.'s generic version of Lipitor (atorvastatin) infringes on two Pfizer patents. [read post]
16 Apr 2018, 2:48 pm
Ranbaxy Laboratories Ltd., Ranbaxy soughtto limit a claim depicting a specific three-dimensionalorientation to a racemic mixture. 457 F.3d 1284, 1288–89(Fed. [read post]
20 Feb 2014, 9:39 am
Ranbaxy Laboratories Ltd., 457 F.3d 1284 (Fed. [read post]
12 Jul 2012, 7:37 am
In the past six months, HUL (Hindustan Unilever Ltd.), Ranbaxy Laboratories, SKS Microfinance Ltd., and Wipro Ltd. have created Ombuds offices. [read post]
